Summary:
Mental health continues to be a leading clinical focus for digital health investors.
Wysa, maker of an AI-backed chatbot that aims to help users work though concerns like anxiety, stress and low mood, recently announced a $20 million Series B funding raise, not long after the startup received FDA Breakthrough Device Designation to use its tool to help adults with chronic musculoskeletal pain.
Ramakant Vempati, the company's Cofounder and President, sat down with MobiHealthNews to discuss how the chatbot works, the guardrails Wysa uses to monitor safety and quality, and what's next after its latest funding round.
Click here ...
Join eMHIC to read more...
Our Knowledge Bank is available to eMHIC Members, and filled with exclusive articles on thought provoking and ground breaking subject matters. We are continually updating it in line with the rapidly evolving health industry, and the ever-changing requirements of mental health practices as we navigate the pandemic as a planet. To access these articles in full, please login or join us.
